Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-28 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.37 | 5e-27 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-23 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-23 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.33 | 8e-23 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.34 | 5e-21 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-20 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-18 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-17 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-16 |